Phase
Condition
Tourette's Syndrome
Schizotypal Personality Disorder (Spd)
Mood Disorders
Treatment
Placebo
SPG302
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-65
Primary diagnosis of schizophrenia
Clinical laboratory values within normal range or < 1.5 times ULN
Currently prescribed only one antipsychotic medication, with stable dose for atleast 4 weeks
Able and willing to provide written informed consent
Exclusion
Exclusion Criteria:
Any physical or psychological condition that prohibits study completion
Known cardiac disease
Active or history of malignancy in the past 5 years
History of clinically significant CNS event or diagnosis in the past 5 years.
Receipt of investigational products within 30 days
Blood donation within 30 days
Study Design
Study Description
Connect with a study center
Box Hill Hospital - Eastern Health
Box Hill, Victoria 3128
AustraliaActive - Recruiting
Monash
Melbourne, Victoria
AustraliaSite Not Available
Multidisciplinary Alfred Psychiatry Research Centre (MAPrc)
Melbourne, Victoria 3004
AustraliaActive - Recruiting
Multidisciplinary Monash Alfred Psychiatry Research Centre
Melbourne, Victoria 3004
AustraliaActive - Recruiting
CenExel CNS
Garden Grove, California 92845
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.